ClinicalTrials.Veeva

Menu

Weight Loss Maintenance in Primary Care (PrimaryCare)

Drexel University logo

Drexel University

Status

Completed

Conditions

Overweight
Obesity

Treatments

Behavioral: Continued CBT
Behavioral: continued use of meal replacements
Behavioral: reduced energy density education
Behavioral: Weight Loss Phase

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00455780
R01DK066759 (U.S. NIH Grant/Contract)
DK66759 (completed)

Details and patient eligibility

About

After a three month weight loss phase involving the use of meal replacements, participants are randomized into different weight loss maintenance conditions. Aim 1: To test the hypothesis that the meal replacement (MR) and reduced energy density eating (REDE) interventions, when added separately to the LEARN program, will produce superior weight loss maintenance compared to a LEARN-only intervention. Aim 2: To test the hypothesis that the weight loss maintenance condition that combines MRs and REDE will produce better maintenance of weight losses than either individual component and than the LEARN-only condition. Aim 3: To test the hypothesis that the two conditions receiving the REDE intervention will experience longer-lasting improvements in the energy density and nutritional composition of the diet compared to the two non-REDE conditions.

Enrollment

238 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BMI of 30, or BMI of 27 with weight-related comorbidities
  • Access to a telephone and voice mail/answering machine
  • MUST be seeing a primary care physician working with us on this study (in the greater Philadelphia area)

Exclusion criteria

  • Previously/currently diagnosed with an eating disorder
  • Current bi-polar, depression, substance abuse, or dependence disorder
  • Living with someone already enrolled
  • Enrolled in another weight loss program
  • Current disorder/medications affecting body weight or energy expenditure (e.g. thyroid disease)
  • Myocardial infraction within the past three months
  • Unstable angina
  • Nephrotic syndrome/malabsorptive disease
  • Gout attack within the past year
  • Lactating/pregnant (or planning within next two years)
  • Current/recent history of cancer, neurological disease, high creatinine levels, active hepatic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

238 participants in 4 patient groups

MR-/REDE-
Experimental group
Description:
Weight Loss through cognitive behavioral therapy and meal replacement use, and continued therapy for weight loss maintenance.
Treatment:
Behavioral: Weight Loss Phase
Behavioral: Continued CBT
MR+/REDE-
Experimental group
Description:
Weight Loss through cognitive behavioral therapy and meal replacement use, and continued therapy and use of meal replacements for weight loss maintenance.
Treatment:
Behavioral: Weight Loss Phase
Behavioral: continued use of meal replacements
Behavioral: Continued CBT
MR-/REDE+
Experimental group
Description:
Weight Loss through cognitive behavioral therapy and meal replacement use, and continued therapy as well as Reduced Energy Density Education for weight loss maintenance.
Treatment:
Behavioral: reduced energy density education
Behavioral: Weight Loss Phase
Behavioral: Continued CBT
MR+/REDE+
Experimental group
Description:
Weight Loss through cognitive behavioral therapy and meal replacement use, and continued therapy, as well as Reduced Energy Density Education and continued meal replacement use, for weight loss maintenance.
Treatment:
Behavioral: reduced energy density education
Behavioral: Weight Loss Phase
Behavioral: continued use of meal replacements
Behavioral: Continued CBT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems